TCL Archive Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer April 24, 2009
TCL Archive Mihich Subcommittee Recommendations For Augmenting Agents In BRMP Described December 7, 1979
TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI. June 11, 2004
TCL Archive In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind January 23, 1976
